Tag: HIV

February 15, 2018

Argos Announces Issuance of Patent Covering the Foundation for Manufacturing its HIV Immunotherapy

Argos Therapeutics (NASDAQ:ARGS), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis® precision immunotherapy...
February 5, 2018

5 Pharmaceutical Stocks on the TSX and TSXV

Opportunities abound when it comes to TSX pharmaceutical stocks, particularly those of the nano or micro cap variety, we're profiling...
January 8, 2018

Top Pharma Stocks of 2017

INN has compiled a list of the top performing pharma stocks of 2017.
December 13, 2017

Lexaria Bioscience Receives U.S. Patent Award for its DehydraTECH(tm) Delivery of THC, NSAIDs, Nicotine and Vitamins

Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") a drug delivery platform innovator, announces the United States...
November 9, 2017

GeoVax Reports 2017 Third Quarter Financial Results

GeoVax Labs announced its financial results for the third quarter of 2017.
October 31, 2017

NuLife Shares Details of Proposed Merger

NuLife Sciences announced the signing of a letter of intent to undertake a formal merger with Ensysce Biosciences.
October 4, 2017

Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab Presented at IDWeek 2017™

Theratechnologies (TSX:TH) has announced 48-week efficacy and safety results for ibalizumab in patients infected with multidrug resistant HIV-1 that completed...